Combining HAIC and Sorafenib as a Salvage Treatment for Patients with Treatment-Failed or Advanced Hepatocellular Carcinoma: A Single-Center Experience

Background: Hepatic arterial infusion chemotherapy (HAIC) has been proven to be an effective treatment for advanced HCC. In this study, we present our single-center experience of implementing combined sorafenib and HAIC treatment for these patients and compare the treatment benefit with that of sora...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chia-Bang, Chen, Chun-Min, Tzeng, Ruo-Han, Chou, Chen-Te, Su, Pei-Yuan, Hsu, You-Chuen, Yang, Cheng-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003950/
https://www.ncbi.nlm.nih.gov/pubmed/36902673
http://dx.doi.org/10.3390/jcm12051887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003950/
https://www.ncbi.nlm.nih.gov/pubmed/36902673
http://dx.doi.org/10.3390/jcm12051887

Ejemplares similares